Legal & General Group
CUE icon

Legal & General Group’s Cue Biopharma CUE Stock Holding History

Legal & General Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-140
Closed -$7.96K – 3441
2024
Q1 		$7.96K Hold
140
– – ﹤0.01% 3249
2023
Q4 		$11.1K Hold
140
– – ﹤0.01% 3213
2023
Q3 		$9.68K Hold
140
– – ﹤0.01% 3274
2023
Q2 		$15.4K Buy
+140
New +$16.5K ﹤0.01% 3220
2022
Q3 		– Sell
-81
Closed -$6K – 3461
2022
Q2 		$6K Sell
81
-717
-90% -$83.9K ﹤0.01% 3429
2022
Q1 		$116K Hold
798
– – ﹤0.01% 2829
2021
Q4 		$270K Buy
798
+314
+65% +$121K ﹤0.01% 2596
2021
Q3 		$211K Buy
484
+180
+59% +$62.8K ﹤0.01% 2674
2021
Q2 		$106K Sell
304
-12
-4% -$4.65K ﹤0.01% 2712
2021
Q1 		$115K Buy
316
+6
+2% +$2.47K ﹤0.01% 2581
2020
Q4 		$116K Hold
310
– – ﹤0.01% 2545
2020
Q3 		$140K Sell
310
-38
-11% -$21.9K ﹤0.01% 2418
2020
Q2 		$256K Buy
348
+244
+235% +$177K ﹤0.01% 2309
2020
Q1 		$44K Sell
104
-38
-27% -$18.4K ﹤0.01% 2629
2019
Q4 		$68K Buy
142
+24
+20% +$7.54K ﹤0.01% 2710
2019
Q3 		$30K Buy
118
+30
+34% +$7.21K ﹤0.01% 2962
2019
Q2 		$20K Hold
88
– – ﹤0.01% 3190
2019
Q1 		$20K Hold
88
– – ﹤0.01% 3088
2018
Q4 		$12K Hold
88
– – ﹤0.01% 3230
2018
Q3 		$24K Hold
88
– – ﹤0.01% 3129
2018
Q2 		$31K Buy
88
+36
+69% +$14.3K ﹤0.01% 2999
2018
Q1 		$22K Buy
+52
New +$23.7K ﹤0.01% 3084

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Legal & General Group's CUE Position: Q2 2024 in Review

Legal & General Group sold out of Cue Biopharma (CUE) in Q2 2024, closing a stake of 140 shares — an estimated $7.96K sold.

Legal & General Group first reported a position in CUE in Q1 2018 and held it in 22 quarters. The position peaked at $270K in Q4 2021. 75 funds tracked by Wall St. Rank hold CUE as of Q2 2024.

  • Legal & General Group reported no remaining Cue Biopharma position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 140 Cue Biopharma shares in Q2 2024, an estimated $7.96K.
  • Legal & General Group first reported a position in Cue Biopharma in Q1 2018 and held it in 22 quarters.
  • Legal & General Group's Cue Biopharma position peaked at $270K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.